Skip to content

Effect of Inhalation of Low Dose CO2 on Exercise Performance at High Altitude

Effect of Supplement of CO2 Using Novel Portable Device on Exercise Performance at High Altitude

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05798416
Enrollment
28
Registered
2023-04-04
Start date
2023-02-15
Completion date
2023-04-29
Last updated
2023-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Mountain Sickness, High Altitude, Inhalation; Gas

Keywords

High altitude, Exercise performance, CO2 inhalation

Brief summary

High altitude (\>2400 m) is associated with decreased atmosphere pressure leading to hypoxia which in turn impairs exercise capacity and causes acute mountain sickness (AMS). It is noted that adding CO2 might be beneficial to improve hypoxia and exercise performance at high altitude. However, no device is currently available that can supply a constant low dose of CO2 during free movement at high altitude. We have recently invented a portable device which is small and light enough for supplement of low dose CO2 during field exercise at high altitude.

Detailed description

Objective: To determine whether the supplement of low-dose CO2 by the novel device could improve exercise performance at high altitude. Methods: The lowlanders (\<500m) who have no history of travelling to high altitude (\>1000m) a year before the study will be recruited. And the subjects who are high-altitude residents and have not left high altitude over the last twelve months will also be recruited for the study. Subjects will be randomly and blindly given either CO2 mixed with air or air alone during endurance shuttle walking test (ESWT). Blood gases will be measured before and after inhalation of CO2. ESWT time, ventilation per minute (VE), blood oxygen saturation (SPO2), and end-tidal CO2 concentration (ETCO2) will be measured during exercise and will be compared during inhalation of CO2 and during inhalation of ambient air.

Interventions

DRUGExercise under inhalation CO2

Participants perform shuttle walk test at high altitude while using the novel portable device for inhalation of CO2

OTHERExercise under inhalation ambient air

Participants perform shuttle walk test at high altitude while inhaling ambient air

Sponsors

State Key Laboratory of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Healthy lowlanders (\<500m) who have no history to travel to high altitude (\>1000m) a year before the study. 2. Healthy high altitude (4500m) residents who have not left the inhabited area over the last twelve months before the study.

Exclusion criteria

1\. Subjects with cardiovascular diseases, respiratory diseases and neuromuscular diseases which could affect exercise.

Design outcomes

Primary

MeasureTime frameDescription
Change of the distance in walking test48 hoursChanges in walking distance under inhalation of CO2 and ambient air

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026